Download PDF

Other users also viewed these articles

Prevalence of metabolic associated fatty liver disease (MAFLD) in patients with gallstone disease. Study on a cohort of cases in South-Southeastern Mexico F. Roesch-Dietlen; A.G. Pérez-Morales; P. Grube-Pagola; M. González-Santes; F. Díaz-Roesch; A. Triana-Romero; L. Roesch-Ramos; J.M. Remes-Troche; M. Cruz-Aguilar;
Rev Gastroenterol Mex. 2023;88:225-31
Prevalence and importance of periodontal disease in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) in Veracruz L. Roesch-Ramos; D.N. Guzmán-Uzcanga; S. Nolasco-Polito; S. Pérez-Pérez; F. Moreno-Marín; R.M. Francisco; H.R. Ordaz-Álvarez; F.B. Roesch-Dietlen; J.M. Remes-Troche; A.D. Cano-Contreras;
10.1016/j.rgmxen.2025.12.005
Beyond conventional physical examination in hepatology: POCUS J.A. Velarde-Ruiz Velasco; D.K. Tapia Calderón; E. Llop Herrera; G. Castro Narro; E.S. García Jiménez; E. Cerda Reyes; F. Higuera de la Tijera; A.D. Cano Contreras; R. Moreno Alcántar; R.M. Chávez Ramírez; J.L. Calleja Panero;
Rev Gastroenterol Mex. 2023;88:381-91